ANI Pharmaceuticals Inc expected to post earnings of 68  cents a share - Earnings Preview

ANI Pharmaceuticals

07/08/2023 16:56

* ANI Pharmaceuticals Inc  ANIP.OQ   ANIP.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 9. 
    * The Baudette Minnesota-based  company is expected to
report  a
33.6% increase in revenue to $98.698 million from $73.86 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ANI Pharmaceuticals
Inc
is for earnings of 68 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ANI
Pharmaceuticals Inc is $60​, above​ its last closing price
of $53.77. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.36        0.35       1.17      Beat    231.9
 Dec. 31 2023  0.66        0.67       0.76      Beat    13.1
 Sep. 30 2022  0.55        0.55       0.64      Beat    15.8​
 Jun. 30 2022  0.22        0.22       0.13      Missed  -40.9
 ​​Mar.        0.10        0.09       -0.12     Missed  -228.6
 31 2022                                                
 Dec. 31 2021  0.82        0.74       0.54      Missed  -27​
 Sep. 30 2021  0.70        0.70       1.01      Beat    44.3
 Jun. 30 2021  0.65        0.69       0.67      Missed  -2.2
 This summary was machine generated August 7 at 15:56 GMT.  All
figures in US dollars  unless otherwise stated